Spero Biopharma Overview
Spero Biopharma is the developer of Ladostigil, a drug designed to treat mild cognitive impairment before it progresses to Alzheimer's disease.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.sperobio.com/ |
Locations
Ramat Hasharon, Israel
Photos & Videos
No files yet
Spero Biopharma Business
Business models
B2B
Product stage
Clinical Trial
Employees
1-10
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsTags (5)
alzheimers-diseasepharmaceuticalsneurologypharma-companiesdrug-discoveryGeographic Markets
United StatesSpero Biopharma Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Pre-Funding
Funding stage
0
Total rounds
0
Investors
Spero Biopharma Lifecycle
Spero Biopharma News
0 articlesNo news articles.
Spero Biopharma Team
Marta Weinstock-Rosin
Founder
Founder
Employee Info
| Employees (range) | 1-10 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
Spero Biopharma Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 79/100 |
| Missing | description, news, not claimed, video or image, funding rounds, external profile |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 516044435 |
| Crunchbase | spero-biopharma |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Paul Weisko |
| Updater email | pweisko@gmail.com |
| Last update | 2021-03-11T00:00:00.000Z |
| Created | 2019-07-22T00:00:00.000Z |